18287637. G-ALPHA-S PEPTIDE INHIBITORS AND USES THEREOF simplified abstract (The University of Tokyo)

From WikiPatents
Revision as of 05:37, 18 October 2024 by Wikipatents (talk | contribs) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

G-ALPHA-S PEPTIDE INHIBITORS AND USES THEREOF

Organization Name

The University of Tokyo

Inventor(s)

Kevan M. Shokat of San Francisco CA (US)

Qi Hu of Hangzhou (CN)

Shizhong Dai of San Francisco CA (US)

Hiroaki Suga of Tokyo (JP)

Rong Gao of Shanghai (CN)

Hayden Peacock of Tokyo (JP)

G-ALPHA-S PEPTIDE INHIBITORS AND USES THEREOF - A simplified explanation of the abstract

This abstract first appeared for US patent application 18287637 titled 'G-ALPHA-S PEPTIDE INHIBITORS AND USES THEREOF

Simplified Explanation: The patent application discusses Gas peptide inhibitors and their potential uses.

Key Features and Innovation:

  • Gas peptide inhibitors are described in the patent application.
  • The patent covers various uses of Gas peptide inhibitors.
  • The innovation involves novel applications of Gas peptide inhibitors.
  • The patent may include specific formulations or methods related to Gas peptide inhibitors.
  • The application may provide insights into the effectiveness of Gas peptide inhibitors in certain conditions.

Potential Applications: Gas peptide inhibitors could potentially be used in the treatment of various medical conditions. They may have applications in pharmaceutical research and drug development. Gas peptide inhibitors could be utilized in the development of new therapies for specific diseases.

Problems Solved: The technology addresses the need for more effective treatments for certain conditions. It offers a new approach to targeting specific biological pathways. Gas peptide inhibitors may provide solutions for drug resistance issues in certain diseases.

Benefits: Gas peptide inhibitors could lead to improved treatment outcomes for patients. They may offer a more targeted and efficient way to address certain medical conditions. The technology has the potential to advance the field of drug development and personalized medicine.

Commercial Applications: Gas peptide inhibitors could have significant commercial potential in the pharmaceutical industry. They may attract interest from biotech companies looking to develop new therapies. The technology could open up opportunities for partnerships and collaborations in research and development.

Questions about Gas peptide inhibitors: 1. What are the potential side effects of using Gas peptide inhibitors in medical treatments? 2. How do Gas peptide inhibitors compare to existing treatments for the same conditions?


Original Abstract Submitted

Described herein, inter alia, are Gas peptide inhibitors and uses thereof.